tiprankstipranks
Aileron Therapeutics regains compliance with Nasdaq listing requirements
The Fly

Aileron Therapeutics regains compliance with Nasdaq listing requirements

Aileron Therapeutics announced that it received written notice on November 28, 2022 from The Nasdaq Stock Market noting that Aileron has regained compliance with the minimum bid price requirement under Listing Rule 5550(a)(2), which requires the company to maintain a minimum closing bid price of $1.00 per share, and the matter is now closed. Nasdaq staff made this determination after Aileron’s closing bid price was above $1.00 per share for 10 consecutive business days from November 11, 2022 to November 25, 2022.

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on ALRN:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles